DERMOSCOPIC FEATURES OF CHRONIC PLAQUE PSORIASIS AND THEIR CORRELATION WITH CLINICAL DISEASE SEVERITY: A CROSS-SECTIONAL OBSERVATIONAL STUDY

Main Article Content

Dr Pooja Varshney
Dr Navneet Dev

Keywords

Psoriasis, Dermoscopy, Dermoscopic Features, Chronic Plaque Psoriasis, PASI Score, Disease Severity, Dotted Vessels, Hemorrhagic Dots, White Circles, Dermoscopic Vascular Patterns

Abstract

Background: Psoriasis is a chronic inflammatory dermatosis characterized by variable clinical severity. Dermoscopy provides a non-invasive method for visualizing vascular and surface changes that may not be readily appreciated clinically. The present study was undertaken to evaluate dermoscopic features of chronic plaque psoriasis and determine their relationship with disease severity.
Methods: This cross-sectional observational study included 100 patients with chronic plaque psoriasis. Demographic and clinical characteristics were recorded, and disease severity was assessed using the Psoriasis Area and Severity Index (PASI). Dermoscopic examination was performed to document vascular, scaling and other characteristic dermoscopic features. Patients were categorized according to PASI severity, and the association between dermoscopic findings and disease severity was assessed.
Results: Of the 100 patients, 62 (62%) were males and 38 (38%) were females. The most common age group was 31–40 years (27%). Mild, moderate and severe psoriasis were observed in 47%, 28% and 25% of patients, respectively. Regularly distributed dotted vessels were the most common dermoscopic finding (82%), followed by white scales (76%) and red background (71%). Hemorrhagic dots/globules were observed in 42% and white circles in 31% of patients. A predefined positive dermoscopic pattern was present in 25 patients (25%). Among these 25 patients, 13 (52%) had severe psoriasis. The mean PASI score was higher among patients with the positive dermoscopic pattern (12.8 ± 3.6) than among those without it (5.9 ± 3.1). Positive correlations were observed between PASI and several vascular dermoscopic features.
Conclusion: Dermoscopy demonstrated characteristic vascular and surface changes in chronic plaque psoriasis. The higher frequency of selected dermoscopic findings among patients with greater PASI scores suggests that dermoscopy may provide useful complementary information for clinical assessment of psoriasis severity. Further studies with larger samples and longitudinal follow-up are warranted to validate these associations.


 


 

Abstract 0 | PDF Downloads 0

References

1.Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205-212. doi:10.1111/jdv.13854.
2.Fredriksson T, Pettersson U. Severe psoriasis—oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-244. doi:10.1159/000250839.
3.Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. 2011;303(1):1-10.
4.Errichetti E. Dermoscopy of inflammatory dermatoses (inflammoscopy): an up-to-date overview. Dermatol Pract Concept. 2019;9(3):169-180. doi:10.5826/dpc.0903a01.
5.Errichetti E, Zalaudek I, Kittler H, Apalla Z, Argenziano G, Bakos R, et al. Standardization of dermoscopic terminology and basic dermoscopic parameters to evaluate in general dermatology (non-neoplastic dermatoses): an expert consensus on behalf of the International Dermoscopy Society. Br J Dermatol. 2020;182(2):454-467. doi:10.1111/bjd.18125.
6.Golińska J, Sar-Pomian M, Rudnicka L. Dermoscopic features of psoriasis of the skin, scalp and nails—a systematic review. J Eur Acad Dermatol Venereol. 2019;33(4):648-660. doi:10.1111/jdv.15344.
7.Lallas A, Apalla Z, Argenziano G, Gachon J, González-Fernández D, Longo C, et al. Dermoscopic patterns of common inflammatory skin diseases. J Eur Acad Dermatol Venereol. 2013;27(8):e405-e411.
8.Lallas A, Kyrgidis A, Tzellos TG, Apalla Z, Karakyriou E, Karatolias A, et al. Accuracy of dermoscopic criteria for the diagnosis of psoriasis, dermatitis, lichen planus and pityriasis rosea. Br J Dermatol. 2012;166(6):1198-1205.
9.Errichetti E, Lallas A, Apalla Z, Di Stefani A, Stinco G. Dermoscopic criteria of psoriasis: systematic review and meta-analysis. Dermatology. 2016;232(2):200-210.
10.Lallas A, Zalaudek I, Argenziano G, Longo C, Moscarella E, Di Lernia V, et al. Dermoscopic pattern of psoriatic lesions on specific body sites. Dermatology. 2014;228(3):250-254.
11.De Angelis R, Bugatti L, Del Medico P, Nicolini M, Filosa G. Videocapillaroscopic findings in the microcirculation of psoriatic plaques. Dermatology. 2002;204(3):236-239.
12.Lallas A, Apalla Z, Sardana K, Kauer M, Robles F, Cavalcanti SM, et al. Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents. Dermatology. 2017;233(2-3):175-181.
13.Kim GW, Jung HJ, Ko HC, Kim MB, Lee WJ, Lee SJ, et al. Dermoscopy can be useful in differentiating scalp psoriasis from seborrhoeic dermatitis. Br J Dermatol. 2011;164(3):652-656.
14.Long FY, Zhang ZQ, He F, Tu J, Yin Z, Xia JP, et al. Dermoscopic features of nail psoriasis: positive correlation with the severity of psoriasis. J Dermatol. 2021;48(6):894-901. doi:10.1111/1346-8138.15908.
15.Errichetti E, Lallas A, Apalla Z, Di Stefani A, Stinco G. Dermoscopy in general dermatology: a practical overview. Dermatol Clin. 2018;36(3):237-249.
16.Golińska J, Sar-Pomian M, Rudnicka L. Dermoscopic features of psoriasis of the skin, scalp and nails—a systematic review. J Eur Acad Dermatol Venereol. 2019;33(4):648-660.
17.Lallas A, Argenziano G, Apalla Z, Gourhant JY, Zaballos P, Di Lernia V, et al. Dermoscopic patterns of common inflammatory skin diseases. J Eur Acad Dermatol Venereol. 2014;28(7):871-878.
18.Errichetti E. Dermoscopy of inflammatory dermatoses (inflammoscopy): an up-to-date overview. Dermatol Pract Concept. 2019;9(3):169-180.
19.Lallas A, Argenziano G, Apalla Z, Moscarella E, Longo C, Zalaudek I. Dermoscopic vascular patterns in psoriasis and their clinical relevance. Dermatol Pract Concept. 2015;5(4):1-6.
20.Errichetti E, Piccirillo A, Stinco G. Clinical and dermoscopic response predictors in psoriatic patients undergoing narrowband ultraviolet B phototherapy: results from a prospective study. Int J Dermatol. 2018;57(7):e24-e29. doi:10.1111/ijd.13983.
21.Lallas A, Argenziano G, Apalla Z, Moscarella E, Longo C, Zalaudek I. Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents. Dermatology. 2017;233(2-3):175-181.
22.Lallas A, Apalla Z, Tzellos T, Lefaki I, Ioannides D, Sotiriou E, et al. Dermoscopic pattern of psoriatic lesions on specific body sites. Dermatology. 2014;228(3):250-254